US Broker Ratings

Alnylam Pharmaceuticals (ALNY) Stock Analysis: A Biotech Powerhouse with 42% Potential Upside

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a leading player in the biotechnology sector, continues to captivate investor interest with its innovative approach to therapeutics. This Cambridge, Massachusetts-based..

Medtronic plc (MDT) Stock Analysis: Exploring a 22.87% Upside Potential

Medtronic plc (MDT) stands as a formidable entity in the healthcare sector, specifically within the medical devices industry. Headquartered in Galway, Ireland, Medtronic boasts a market..

Danaher Corporation (DHR) Stock Analysis: Unveiling a 35.50% Upside Potential Amidst Robust Analyst Support

For those keeping a close eye on the healthcare sector, Danaher Corporation (NYSE: DHR) represents a compelling investment option. With a market capitalization of $138.25 billion,..

HCA Healthcare (HCA) Stock Analysis: Evaluating Growth in a Competitive Healthcare Sector

Investors eyeing the healthcare sector for stable and potentially lucrative opportunities may find HCA Healthcare, Inc. (NYSE: HCA) a compelling case study. With a market capitalization..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Analyst Consensus Points to a 35% Upside

For investors eyeing the healthcare sector, IQVIA Holdings, Inc. (NYSE: IQV) stands out as a formidable player within the diagnostics and research industry. Based in Durham,..

ResMed Inc. (RMD) Stock Analysis: Navigating the Healthcare Sector with a 17.64% Upside Potential

ResMed Inc. (RMD), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, offers intriguing prospects for investors. With a market..

Mettler-Toledo International (MTD) Stock Analysis: Unpacking a 24% Potential Upside with Diagnostic Precision

Mettler-Toledo International Inc. (NYSE: MTD) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of..

Sanofi (SNY) Stock Analysis: Exploring a Potential 29.47% Upside in the Healthcare Giant

Sanofi (SNY), a leading player in the healthcare sector, is capturing investor attention with a promising potential upside of 29.47%. With a market capitalization of $107.59..

Cencora, Inc. (COR) Stock Analysis: A Healthcare Giant with a 14% Upside Potential

Cencora, Inc. (NYSE: COR), a formidable player in the healthcare sector, has caught the attention of investors with its robust market presence and potential for significant..

Boston Scientific Corporation (BSX) Stock Analysis: Unpacking a 46.10% Potential Upside

Boston Scientific Corporation (NYSE: BSX), a titan in the medical devices industry, stands out with a striking potential upside of 46.10%, capturing investor attention. With its..

Stryker Corporation (SYK) Stock Analysis: Exploring a 16.55% Potential Upside in the Medical Device Sector

Stryker Corporation (SYK), a prominent player in the healthcare sector, primarily focuses on medical devices. With a market capitalization of $139.51 billion, Stryker stands as a..

Eli Lilly and Company (LLY) Stock Analysis: Unveiling a 22.62% Potential Upside

Eli Lilly and Company (NYSE: LLY), a stalwart in the healthcare sector, continues to capture the attention of investors with its promising growth prospects and significant..

Merck & Company (MRK) Stock Analysis: Strong Growth Potential with a 9.87% Upside

Merck & Company, Inc. (NYSE: MRK) stands as a formidable entity in the global healthcare sector, with its roots deeply entrenched in the drug manufacturing industry...

Novo Nordisk A/S (NVO) Stock Analysis: Navigating a 25% Upside in the Healthcare Sector

Novo Nordisk A/S (NVO), a stalwart in the healthcare sector, holds a commanding presence in the drug manufacturing industry with a focus on diabetes and obesity..

Prothena Corporation plc (PRTA) Stock Analysis: Eyeing a 116.70% Upside with Promising Biotech Innovations

Prothena Corporation plc (NASDAQ: PRTA), a biotechnology company headquartered in Dublin, Ireland, is attracting significant attention from investors due to its robust late-stage clinical pipeline and..

Emergent BioSolutions Inc. (EBS): Analyst Ratings Signal Nearly 60% Upside Potential

Emergent BioSolutions Inc. (NYSE: EBS) presents an intriguing opportunity for investors, particularly those focused on the healthcare sector. Specializing in preparedness and response solutions for various..

AngioDynamics, Inc. (ANGO) Stock Analysis: A 77.86% Potential Upside in Healthcare’s Innovative Frontier

AngioDynamics, Inc. (NASDAQ: ANGO), a leading player in the healthcare sector specializing in medical instruments and supplies, offers a tantalizing opportunity for investors with a potential..

Cel-Sci Corporation (CVM): Investor Outlook on Potential 962.50% Upside in Biotechnology Sector

Cel-Sci Corporation (NASDAQ: CVM), a clinical-stage biotechnology company with a market capitalization of $33.83 million, is capturing investor attention with a staggering potential upside of 962.50%...

Fortrea Holdings Inc. (FTRE) Stock Analysis: Exploring a Potential 45.53% Upside in the Biotechnology Sector

Fortrea Holdings Inc. (FTRE), a promising player in the biotechnology industry, presents a compelling opportunity for investors searching for growth in the healthcare sector. With its..

Oric Pharmaceuticals, Inc. (ORIC) Stock Analysis: 53% Upside Potential Amid Strong Buy Ratings

Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) has emerged as a captivating story in the biotechnology sector, offering investors a promising opportunity with a potential upside of 53.29%...

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds